AstraZeneca has announced the suspension of a 200 million pound investment in the research center in Cambridge, affecting 1,000 jobs.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
22:51
Columbia will resume coal exports to Israel, previously suspended, announces the Minister of Commerce.
22:43
Andrei Cornea: Order from disorder
22:33
Paramount accused Mark Ruffalo of perpetuating anti-Semitic stereotypes through comments about the merger with Warner Bros
22:14
Hungary: Péter Magyar announces that reactor 3 at the Paks nuclear power plant could be restarted ahead of schedule due to the work carried out and the rising level of the Danube.
21:54
A Romanian mineral water company is mocking the US president, Donald Trump, in a viral advertisement.
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
